Illegal Activity
none
Blackmail
none
Date
2005-01-15
Document Type
Program Statement
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:44
Summary
This program statement outlines the policies and procedures for pharmacy services within the Federal Bureau of Prisons, covering medication management, controlled substances, patient safety, and error reporting. It emphasizes compliance with federal regulations and aims to provide quality pharmaceutical care to inmates.
Metadata
- Subject
- Pharmacy Services
- Sender
- Harley G. Lappin, Director
- Recipients
- —
- Document ID
- P6360.01
- Date
- 2005-01-15
Relationships 7
| Entity 1 | Relationship | Entity 2 | Description |
|---|---|---|---|
| Chief Pharmacist | Reporting | HSA | Consultant/contract pharmacists report to the Health Services Administrator (HSA) with a written monthly report of pharmacy activities. |
| Chief Pharmacist | Reporting | BOP Chief Pharmacist | Local P&T Meeting minutes will be sent to the BOP Chief Pharmacist within 30 days of the end of the quarter. |
| Chief Pharmacist | Compliance | DEA | The Chief Pharmacist is the responsible authority for all DEA controlled substances. |
| HSA | Security | Warden | The HSA will ensure that a duplicate set of keys or combinations of all vaults and safes in the HSU will be sealed in separate envelopes, plainly marked with contents, and filed in the Warden's or security officer's vault or safe. |
| QIP coordinator | Reporting | Chief Pharmacist | The Medication Error form will be submitted to the institution Chief Pharmacist who will report this information to the QIP Coordinator. |
| QIP coordinator | Reporting | HSA | The QIP coordinator will furnish a copy of the Medication Error Report or a summary of all reports, to the HSA. |
| P&T Committee | Review | QIP coordinator | The P&T Committee will suggest process improvements that result from the review of medication errors. |
Notable Quotes 2
An inmate's access to quality, necessary, cost-effective pharmaceutical care will be provided.
The monitoring and reporting of medication errors will be conducted in a blame-free manner and focus primarily on systems and continuous quality improvement activities rather than on individuals.
Public Knowledge
- Context
- This document outlines internal policies and procedures for the Federal Bureau of Prisons, which are not typically public knowledge.
Legal Compliance
- Compliance with the Controlled Substances Act of 1970 and related regulations (21 CFR Chapter II, Part 1300).
- Adherence to DEA regulations regarding controlled substances (21 CFR Part 1301.72).
- Compliance with Title 42 CFR 8 regarding methadone use for detoxification or maintenance of opioid addicted patients.
- Compliance with FDA regulations regarding adverse reaction reporting and drug recalls.
Raw Analysis JSON
click to expand
Themes
Legal matters/litigationEmployment/staffingBusiness dealingsCommunications/correspondenceLegal matters/litigationComplianceHealthcarePharmacyControlled SubstancesMedication ErrorsPatient Safety
Organizations 20
U.S. Department of JusticeFederal Bureau of PrisonsBureau of PrisonsBOPAmerican Correctional AssociationFood and Drug Administration (FDA)Drug Enforcement Administration (DEA)Central OfficeRegional DEA OfficeHealth Services DivisionDepartment of Health and Human Services (DHHS)Substance Abuse and Mental Health Services Administration (SAMHSA)General Services Administration (GSA)MedicaidAids Drugs Assistance Programs (ADAP)Community Corrections Manager (CCM)VADODPHSAmerican Society of Health Systems Pharmacists (ASHP)
Locations 1
Washington, DC
Text Analysis
- Tone
- Professional
- Purpose
- To provide guidance for pharmacy services within the Federal Bureau of Prisons.
- Significance
- This document outlines the policies and procedures for pharmacy operations within federal correctional institutions, covering aspects such as medication management, controlled substances, patient safety, and error reporting.
File Info
- File Name
- EFTA00039312.txt
- Dataset
- dataset_9
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:44:28.274454
- DOJ Source
- View on DOJ